Request that the FDA grant permission to file an application for an abbreviated new animal drug application (ANADA) for a generic Oral solution for Trilostane that differs from the pioneer product, VETORYL CAPSULES, sponsored by Dechra Veterinary Products. under NADA 141-291 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-P-0529

Request that the FDA grant permission to file an application for an abbreviated new animal drug application (ANADA) for a generic Oral solution for Trilostane that differs from the pioneer product, VETORYL CAPSULES, sponsored by Dechra Veterinary Products. under NADA 141-291

Documents

Comments

Description

OPEN

Key Dates

Comment Period OpensJan 16, 2026

Documents

Type	Title	Posted	Comments	Status
Other	Response Letter	Mar 20, 2026	--

Keywords

CVM

Suitability Petition

Felix Pharmaceuticals Pvt. Ltd.

permission to file an application

abbreviated new animal drug application (ANADA)

for a generic Oral solution for Trilostane that

differs from the pioneer product,

VETORYL CAPSULES, sponsored by

Data from Regulations.gov